Brief: Global Bioenergies: Successful Completion Of Toxicological Studies For Its First Key Ingredient
Oct 26 (Reuters) - GLOBAL BIOENERGIES SA ALGBE.PA :
* SUCCESSFUL COMPLETION OF TOXICOLOGICAL STUDIES FOR ITS
FIRST KEY
INGREDIENT
* NOW PLANS TO COMMERCIALISE THIS INNOVATION FROM 2021
Source text for Eikon: ID:nGNE1QvF8p
Further company coverage: ALGBE.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Global Bioenergies SA
See all newsBrief: Global Bioenergies Says Takeover Offers Review Postponed To November 24, 2025
Brief: Global Bioenergies Says 4 Offers Submitted For Global Bioenergies' Assets
Brief: Global Bioenergies SA Launches Search For Buyer
Brief: Global Bioenergies Completes Basic Engineering Phase On Cosmetics Plant Project
Brief: Global Bioenergies Has Received Letters Of Intent For Its Plant Project